Kaiser Permanente Northern California deepens its COVID-19 research agenda October 13, 2020 Division of Research physician researchers and other investigators examine the pandemic’s effects from all angles. Read more
Telehealth appointments improve follow-up care for heart failure October 1, 2020 A new Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up for heart failure. Read more
Active tuberculosis linked to higher long-term risk of death September 29, 2020 A Kaiser Permanente study found that increasing tuberculosis screening and prevention efforts could potentially help improve life expectancy. Read more
New virtual, innovative clinical trial for adults at high risk for respiratory illnesses August 25, 2020 Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease. Read more
Kaiser Permanente joins phase 3 clinical trial for COVID-19 vaccine August 13, 2020 The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon. Read more
Living longer and better after cancer June 12, 2020 Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life. Read more
On-demand HIV prevention pills worked well, study shows June 4, 2020 Kaiser Permanente Northern California researchers say new as-needed PrEP regimen may increase use of the highly effective medication. Read more
Large drop in hospitalized heart attack patients seen during COVID-19 pandemic May 27, 2020 Kaiser Permanente research in Northern California backs anecdotal reports of people avoiding emergency care because of concerns over the coronavirus. Read more
Permanente Medicine powers coordinated effort around remdesivir clinical research trials May 21, 2020 Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions. Read more